U.S. Markets open in 7 hrs 51 mins

Innovation Pharmaceuticals Inc. (IPIX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2290-0.0261 (-10.25%)
At close: 3:56PM EDT

Innovation Pharmaceuticals Inc.

301 Edgewater Place
Suite 100
Wakefield, MA 01880
United States
978 921 4125
http://www.ipharminc.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees4

Key Executives

NameTitlePayExercisedYear Born
Mr. Leo EhrlichChairman, CEO, CFO, Principal Accounting Officer & Sec.465.85kN/A1958
Ms. Jane HarnessSr. VP of Clinical Sciences & Portfolio Management365.75kN/A1968
Dr. W. James AlexanderConsultantN/AN/A1950
Mr. Jim BoeheimBus. AdvisorN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It develops Brilacidin, a lead drug compound for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company also develops Kevetrin, a lead anti-cancer compound for treating ovarian cancer. It has license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

Corporate Governance

Innovation Pharmaceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.